Dear Spiral user, We’re pleased to introduce Helix, https://helix.imperial.ac.uk/ Imperial’s new repository for research datasets. Please use Helix for all future dataset deposits. There is no change to Spiral - continue depositing as usual. For queries, contact the Research Data Management team at rdm-enquiries@imperial.ac.uk. Kind regards, the Spiral Team. The Spiral team
After asthma: redefining airways diseases.
File(s)
THELANCET-D-16-01609R2.pdf (5.54 MB)
Accepted version
Author(s)
Pavord, ID
Beasley, R
Agusti, A
Anderson, GP
Bel, E
Type
Journal Article
Date Issued
2017-09-11
Date Acceptance
2017-03-07
Citation
Lancet, 2017, 391 (10118), pp.350-400
URI
DOI
ISSN
0140-6736
Publisher
Elsevier
Start Page
350
End Page
400
Journal / Book Title
Lancet
Volume
391
Issue
10118
Copyright Statement
© 2017, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
PII: S0140-6736(17)30879-6
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
OBSTRUCTIVE PULMONARY-DISEASE
EXHALED NITRIC-OXIDE
RANDOMIZED CONTROLLED-TRIAL
PLACEBO-CONTROLLED TRIAL
REFRACTORY EOSINOPHILIC ASTHMA
INHALED FLUTICASONE PROPIONATE
UNCONTROLLED PERSISTENT ASTHMA
CONTROLLED CLINICAL-TRIAL
NECROSIS-FACTOR-ALPHA
EARLY-LIFE INFLUENCES
11 Medical And Health Sciences
Publication Status
Published